Efficacy and safety of long-term, continuous subcutaneous octreotide infusion for patients with different subtypes of KATP-channel hyperinsulinism

Clinical Endocrinology

Volumn 78, Issue 6, 2013, Pages 891-897

  Yorifuji, Tohru ^a   Kawakita, Rie ^a   Hosokawa, Yuki ^a   Fujimaru, Rika ^a   Matsubara, Kousaku ^b   Aizu, Katsuya ^c   Suzuki, Shigeru ^d   Nagasaka, Hironori ^e   Nishibori, Hironori ^f   Masue, Michiya ^f  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b NISHI KOBE MEDICAL CENTER   (Japan)

^c SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^d ASAHIKAWA MEDICAL COLLEGE   (Japan)

^e Takarazuka City Hospital   (Japan)

^f Kizawa Memorial Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORODOPA F 18; ABCC8 PROTEIN; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; DIAZOXIDE; DOPA; GENOMIC DNA; GLUCAGON; GLUCOSE; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; OCTREOTIDE; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DNA SEQUENCE; DRUG EFFICACY; DRUG SAFETY; DRUG UPTAKE; DRUG WITHDRAWAL; ENTERIC FEEDING; EXON; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; GLUCOSE BLOOD LEVEL; GROWTH RETARDATION; HUMAN; HYPERINSULINISM; INFANT; INHERITANCE; INSULIN PUMP; INTRON; JAPANESE; LONG TERM CARE; MALE; MOLECULAR DIAGNOSIS; MONOALLELIC MUTATION; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; NEWBORN; PATERNALISM; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT DURATION;

ATP-BINDING CASSETTE TRANSPORTERS; CHILD DEVELOPMENT; CHILD, PRESCHOOL; CONGENITAL HYPERINSULINISM; DIHYDROXYPHENYLALANINE; FEMALE; FLUORINE RADIOISOTOPES; HUMANS; INFANT; INFANT, NEWBORN; INFUSIONS, SUBCUTANEOUS; KATP CHANNELS; MALE; OCTREOTIDE; POSITRON-EMISSION TOMOGRAPHY; POTASSIUM CHANNELS, INWARDLY RECTIFYING; RECEPTORS, DRUG;

EID: 84876533547     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12075     Document Type: Article

References (26)

1. Arnoux, J.B., Verkarre, V., Saint-Martin, C., et al,. (2011) Congenital hyperinsulinism: current trends in diagnosis and therapy. Orphanet Journal of Rare Diseases 6, 63.
2. Macmullen, C.M., Zhou, Q., Snider, K.E., et al,. (2011) Diazoxide-unresponsive congenital hyperinsulinism in children with dominant mutations of the β-cell sulfonylurea receptor SUR1. Diabetes 60, 1797-1804.
3. Verkarre, V., Fournet, J.C., de Lonlay, P., et al,. (1998) Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia. Journal of Clinical Investigation 102, 1286-1291.
4. de Lonlay, P., Fournet, J.C., Rahier, J., et al,. (1997) Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy. Journal of Clinical Investigation 100, 802-807.
5. Damaj, L., le Lorch, M., Verkarre, V., et al,. (2008) Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism. Journal of Clinical Endocrinology and Metabolism 93, 4941-4947.
6. Menni, F., de Lonlay, P., Sevin, C., et al,. (2001) Neurologic outcomes of 90 neonates and infants with persistent hyperinsulinemic hypoglycemia. Pediatrics 107, 476-479.
7. Beltrand, J., Caquard, M., Arnoux, JB., et al,. (2012) Glucose metabolism in 105 children and adolescents after pancreatectomy for congenital hyperinsulinism. Diabetes Care 35, 198-203.
8. Lyonnet, S., Bonnefont, J.P., Saudubray, J.M., et al,. (1989) Localisation of focal lesion permitting partial pancreatectomy in infants. Lancet 2, 671.
9. Pierro, A., &, Nah, S.A., (2011) Surgical management of congenital hyperinsulinism of infancy. Seminars in Pediatric Surgery 20, 50-53.
10. Barthlen, W., (2011) Surgery in congenital hyperinsulinism-tips and tricks not only for surgeons. A practical guide. Seminars in Pediatric Surgery 20, 56-59.
11. Laje, P., Stanley, C.A., Palladino, A.A., et al,. (2012) Pancreatic head resection and Roux-en-Y pancreaticojejunostomy for the treatment of the focal form of congenital hyperinsulinism. Journal of Pediatric Surgery 47, 130-135.
12. Bruining, G.J., Bosschaart, A.N., Aarsen, R.S., et al,. (1986) Normalization of glucose homeostasis by a long-acting somatostatin analog SMS 201-995 in a newborn with nesidioblastosis. Acta Endocrinol Supplementum (Copenhagen) 279, 334-339.
13. Hindmarsh, P., &, Brook, C.G,. (1987) Short-term management of nesidioblastosis using the somatostatin analogue SMS 201-995. New England Journal of Medicine 316, 221-222.
14. DeClue, T.J., Malone, J.I., &, Bercu, B.B., (1990) Linear growth during long-term treatment with somatostatin analog (SMS 201-995) for persistent hyperinsulinemic hypoglycemia of infancy. Journal of Pediatrics 116, 747-750.
15. Glaser, B., Hirsch, H.J., &, Landau, H., (1993) Persistent hyperinsulinemic hypoglycemia of infancy: long-term octreotide treatment without pancreatectomy. Journal of Pediatrics 123, 644-650.
16. Thornton, P.S., Alter, C.A., Katz, L.E., et al,. (1993) Short- and long-term use of octreotide in the treatment of congenital hyperinsulinism. Journal of Pediatrics 123, 637-643.
17. Mazor-Aronovitch, K., Gillis, D., Lobel, D., et al,. (2007) Long-term neurodevelopmental outcome in conservatively treated congenital hyperinsulinism. European Journal of Endocrinology 157, 491-497.
18. Hussain, K., Blankenstein, O., De Lonlay, P., et al,. (2007) Hyperinsulinaemic hypoglycaemia: biochemical basis and the importance of maintaining normoglycaemia during management. Archives of Disease in Childhood 92, 568-570.
19. Yorifuji, T., Kawakita, R., Nagai, S., et al,. (2011) Molecular and clinical analysis of Japanese patients with persistent congenital hyperinsulinism: predominance of paternally inherited monoallelic mutations in the KATP channel genes. Journal of Clinical Endocrinology and Metabolism 96, E141-E145.
20. 8F]-fluoro- l -dihydroxyphenylalanine positron emission tomography scan for persistent congenital hyperinsulinism in Japan. Clinical Endocrinology (Oxford) 75, 342-346.
21. Cornblath, M., Hawdon, J.M., Williams, A.F., et al,. (2000) Controversies regarding definition of neonatal hypoglycemia: suggested operational thresholds. Pediatrics 105, 1141-1145.
22. Bellanné-Chantelot, C., Saint-Martin, C., Ribeiro, M.J., et al,. (2010) ABCC8 and KCNJ11 molecular spectrum of 109 patients with diazoxide-unresponsive congenital hyperinsulinism. Journal of Medical Genetics 47, 752-759.
23. Ludwig, A., Ziegenhorn, K., Empting, S., et al,. (2011) Glucose metabolism and neurological outcome in congenital hyperinsulinism. Seminars in Pediatric Surgery 20, 45-49.
24. Laje, P., Halaby, L., Adzick, N.S., et al,. (2010) Necrotizing enterocolitis in neonates receiving octreotide for the management of congenital hyperinsulinism. Pediatric Diabetes 11, 142-147.
25. Modan-Moses, D., Koren, I., Mazor-Aronovitch, K., et al,. (2011) Treatment of congenital hyperinsulinism with lanreotide acetate (Somatuline Autogel). Journal of Clinical Endocrinology and Metabolism 96, 2312-2317.
26. Le Quan Sang, K.H., Arnoux, J.B., Mamoune, A., et al,. (2012) Successful treatment of congenital hyperinsulinism with long-acting release octreotide. European Journal of Endocrinology 166, 333-339.